Prospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Jan 28, 2025; 31(4): 99014
Published online Jan 28, 2025. doi: 10.3748/wjg.v31.i4.99014
Table 1 Demographic and clinical characteristics of the participants
Variable
CD with anxiety (n = 16)
CD without anxiety (n = 21)
Healthy controls (n = 20)
P value
Demographic
    Age (years)37.44 ± 7.8936.24 ± 9.2635.75 ± 9.060.8461
    Sex (n, male/female)7/912/910/100.7182
    Education (years)15 (12,16)12 (9,15)12.00 ± 4.030.1713
    Height (m)1.65 ± 0.871.72 (1.58,1.75)1.65 ± 0.090.3583
    Weight (kg)59.08 ± 10.9260.14 ± 12.2255 (50.25,71.5)0.8573
Clinical characteristics
    HADS-A score13.88 ± 3.862.95 ± 1.263.26 ± 1.66< 0.0011,a
    SES-CD13.82 ± 2.735.71 ± 1.97-< 0.0014,a
    WBC, 109/L11.39 ± 2.626.06 ± 1.48-< 0.0014,a
    Hemoglobin, g/L136.69 ± 18.86131 (122.5,140)-0.6423
    ESR, mm/hour29.10 ± 18.2125.88 ± 17.590.5924
    CRP (mg/dL)11.78 ± 5.815.9 (5,10.18)0.0593
    Duration of disease (years)3.36 ± 1.592.10 ± 0.570.465